SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001615774-17-007567
Filing Date
2017-12-22
Accepted
2017-12-22 16:37:59
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2385824
2 filename2.htm EX-10.1 158910
3 filename3.htm EX-10.2 91607
4 filename4.htm EX-10.3 115353
5 GRAPHIC s108517_ex10-1img1.jpg GRAPHIC 3330
6 GRAPHIC s108516_pg3.jpg GRAPHIC 17469
7 GRAPHIC s108516_pg5.jpg GRAPHIC 61242
8 GRAPHIC s108516_pg82.jpg GRAPHIC 162817
9 GRAPHIC s108516_pg89.jpg GRAPHIC 53898
10 GRAPHIC s108516_pg90.jpg GRAPHIC 42605
11 GRAPHIC s108516_pg91.jpg GRAPHIC 43036
12 GRAPHIC s108516_pg92.jpg GRAPHIC 25637
  Complete submission text file 0001615774-17-007567.txt   3318552
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01737 | Film No.: 171273059
SIC: 2834 Pharmaceutical Preparations